Navigation Links
Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer
Date:4/16/2008

or pathway-specific assays to its portfolio of products that will be commercialized for use as diagnostic tests or in clinical research. Xceed has already committed to several other institutions under its Strategic Collaborator program and expects to sign agreements with and install its Ziplex System at six to ten Strategic Collaborators in North America by the end of 2008.

About Xceed Molecular

Xceed's vision is to advance molecular diagnostics by successfully translating novel multiplex tests into routine clinical practice and to create robust diagnostic solutions to improve disease outcomes. Our products comprise the Ziplex(R) System for automated gene-expression analysis (available in the US and Canada for research use only), gene expression services, and pre-configured arrays. Xceed is also developing multiplexed genomic tests for the Ziplex platform, both internally and with strategic partners. Xceed's R&D and manufacturing are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts. For more information, visit http://www.XceedMolecular.com.


'/>"/>
SOURCE Xceed Molecular
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bond Laboratories First Quarter Fiscal 2008 Sales Exceeding Internal Projections
2. Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
3. As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years, Technology will be Called upon to Stem the Tide
4. Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations
5. Old Newsboys Goodfellow Fund of Detroit Has REACHED and EXCEEDED ITS GOAL of $1.375 Million
6. Liberator Medical Holdings Exceeds December Sales
7. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
8. Liberator Medical Supply Exceeds Projected November Sales
9. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
10. The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... The Workgroup for Electronic Data Interchange ... use of health IT to create efficiencies in healthcare ... the United States Government Accountability Office (GAO) for a ... Medicare. The report, “ Potential Uses of Electronically Readable ... the public on Apr. 24, 2015 and examines the ...
(Date:5/1/2015)... Hope For The Warriors® thanks All ... The Warriors® and military families. All American Ford presented ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... collected and matched small autograph fee from fans and ...
(Date:5/1/2015)... 2015 The Quail Creek Relay for Life ... Since 2001, the Quail Creek Relay team has raised almost ... throughout the year, including their biggest event, January’s Dinner and ... , Quail Creek Relay for Life team was established ... Kerwin, fitness director, states, “I was hooked when I learned ...
(Date:5/1/2015)... May 01, 2015 Digital technology and ... pregnant women between prenatal appointments, a preliminary study ... a small sample of low-risk pregnant women, will be ... Washington University Medical Faculty Associates at the 2015 American ... Scientific Meeting, May 2-6. The digital technology used was ...
(Date:5/1/2015)... Veteran Outreach Pittsburgh - Events , The ... VA Vet Centers on May 6, starting at 5 p.m., ... in front of the SouthSide Works Theater, 425 Cinema Drive, ... the documentary, “That Which I Love Destroys Me,” and a ... Please contact Robert Novotney for more information on the VA ...
Breaking Medicine News(10 mins):Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... Innovations, (Pink Sheets: SCLL) ACTIVTox(R) human liver toxicity tests ... standardized human liver cell line to identify potential toxicities ... is available now and can be used to help ... of our ACTIVTox testing system could help prevent recalls ...
... 21 Celator Pharmaceuticals today announced that it ... Inc. (Nasdaq: CEPH ). The ... application of Celator,s proprietary technology to an ongoing ... agreement provides an opportunity to leverage the technology ...
... MDdatacor, Inc ., a leader in health care ... today announced new functionality to support in tracking ... Care Program. The program is a collaboration between Wellmark ... to promote improved quality care and increased efficiency. ...
... Optimize Resources With Imaging, Behavioral and Chronic Management ... is now easier for providers and payors, thanks ... new Milliman Care Guidelines (R) 13th Edition. ... measures within the Care Guidelines, workflow ...
... are out the schoolroom door and off to the ... preventive steps to help protect their hearts.Prevention may be ... exercise, stay away from cigarettes and have check-ups.Be aware ... disorder known as Long QT Syndrome, research shows that ...
... Employer Interest in Their NicheDENVER, May 21 The ... their employees on international business trips to "get proactive" ... the state,s largest travel health provider."We are hearing from ... Reesman, president of Passport Health Colorado. "I think now ...
Cached Medicine News:Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 2Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 3Health News:Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc. 2Health News:Wellmark Leverages MDdatacor Technology to Streamline Immunization Tracking 2Health News:Wellmark Leverages MDdatacor Technology to Streamline Immunization Tracking 3Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 2Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 3Health News:Protect Your Kids' Hearts: Summer Activity Can Trigger Genetic Disorder, Say Results for Life, Sudden Cardiac Arrest Association 2Health News:Protect Your Kids' Hearts: Summer Activity Can Trigger Genetic Disorder, Say Results for Life, Sudden Cardiac Arrest Association 3Health News:H1N1 Scare Causes Businesses to Get Serious About Travel Health 2
(Date:4/30/2015)... 30, 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended March 31, 2015 on Thursday, May ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its first quarter 2015 ...
(Date:4/30/2015)... CUPERTINO, Calif., April 30, 2015  DURECT Corporation (Nasdaq: ... first quarter of 2015.  Total revenues were $4.8 million ... months ended March 31, 2015 as compared to total ... million for the three months ended March 31, 2014.At ... $29.8 million, compared to cash and investments of $34.9 ...
(Date:4/30/2015)... 2015 Pharmacists at Osco Drug have voted to ... Portland, Maine . The newly organized group consists of ... Shaw,s supermarkets throughout Maine . ... in securing them the powerful representation that Teamsters Local 340 ... President of Local 340. "We will work tirelessly, providing them ...
Breaking Medicine Technology:Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 9
... 02, 2007 /PRNewswire-FirstCall/ - YM,BioSciences Inc. ... develops,and commercializes differentiated products for patients ... randomized,placebo-controlled Phase IIb trial of AeroLEF(TM) ... following orthopedic surgery.,AeroLEF(TM) met the primary ...
... 2, 2007 - Acorda Therapeutics, Inc.(R),(Nasdaq: ACOR) ... clinical trial,of Fampridine-SR in people with multiple ... meeting. Andrew Goodman, M.D.,Director of the Multiple ... top-line results on walking ability, leg,strength, spasticity ...
Cached Medicine Technology:YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 2YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7
... an easy-to-use, automated system that enables you ... for managing hemostatic disordersincluding D-Dimer, Von Willebrand ... reflex and rerun testing for greater efficiency ... our high-quality service to help your lab ...
... RX ACCUNET Embolic Protection System is designed ... filter control when performing carotid stenting interventions. ... based filter system that utilizes rapid exchange ... control the filter during catheter manipulations. It ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Medicine Products: